Abstract
AbstractThe complex nature of human brain tissues is important in ensuring accurate diagnosis to save human lives. Research on early detection of brain diseases has gained significant prominence within medical intelligence using highly complex model architectures with only a single label that cannot be verified. This paper introduces an innovative approach to Siamese Network Genetic Algorithm (SN‐GA) leveraging Siamese contrastive learning for classifying brain images across diverse diseases. Our core architecture is a Bi‐Convolutional Neural Network (Bi‐CNN) optimized by a genetic algorithm to enhance brain image classification. Specifically, five widely recognized transfer learning‐based architectures, namely AlexNet, Efficient‐B0, VGG‐16, ResNet‐50, and Inception‐v3, have been incorporated to evaluate the effectiveness of the proposed SN‐GA system. The performance of these models has been rigorously analyzed and compared using two distinct datasets: Brain tumors and Alzheimer's datasets. The experimental results robustly affirm the efficacy of the proposed Siamese model, yielding exceptional levels of accuracy, precision, and recall, all peaking at 97%. These findings underscore the potential and resilience of the optimized Siamese network in the context of brain disease classification, emphasizing its significance in advancing the field of medical imaging and diagnosis, with implications for early intervention and patient care.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.